Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls
Background: Multiple sclerosis (MS) is an autoimmune, neurodegenerative disorder with a strong genetic component that acts in a complex interaction with environmental factors for disease development. CD4+ T cells are pivotal players in MS pathogenesis, where peripherally activated T cells migrate to...
Main Authors: | Berge, T. (Author), Berven, F. (Author), Bos, S.D (Author), Brorson, I.S (Author), Cappelletti, C. (Author), Eriksson, A. (Author), Harbo, H.F (Author), Høgestøl, E.A (Author), Kråbøl, O. (Author), Leikfoss, I.S (Author), Mjaavatten, O. (Author), Vitelli, V. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A
by: Tone Berge, et al.
Published: (2013-02-01) -
Genes, autoimmunity and pathogenesis of rheumatic heart disease
by: Guilherme L, et al.
Published: (2011-01-01) -
Immune dysregulation in myelodysplastic syndrome
by: Chiharu Sugimori, et al.
Published: (2010-01-01) -
A Comparison of Assays for Accurate Copy Number Measurement of the Low-Affinity Fc Gamma Receptor Genes FCGR3A and FCGR3B
by: Abu Bakar, S, et al.
Published: (2015) -
Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis
by: K. Schmitz, et al.
Published: (2017-06-01)